Does breast feeding influence liver biochemistry?

Marianne Hørby Jørgensen1, Peter Ott, Anders Juul

  • 1Department of Paediatrics, Hillerød Hospital, Hillerød, Denmark.

Insights

Breastfeeding may elevate aspartate aminotransferase (AST) and bilirubin in infants, but not indicate liver disease. Human milk factors may induce hepatocytes, supported by higher albumin and AST-IGF-I association.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatal Nutrition
  • Biochemistry

Background:

  • Breastfed infants have higher hyperbilirubinemia risk than formula-fed infants.
  • Early feeding practices may influence infant liver biochemistry.
  • Understanding feeding mode's impact on liver enzymes is crucial for infant health.

Purpose of the Study:

  • To investigate the effect of feeding mode on liver biochemistry in healthy term infants.
  • To compare liver enzyme levels between breast-fed and formula-fed infants.
  • To explore potential factors influencing liver biochemistry based on diet.

Main Methods:

  • Longitudinal study of healthy term infants with monthly feeding mode questionnaires.
  • Blood samples collected at 2, 6, and 9 months of age.
  • Assessed liver biochemistry (albumin, alkaline phosphatase, lactic dehydrogenase, AST, bilirubin), IGF-I, and IGFBP-3.

Main Results:

  • Higher mean AST and bilirubin levels observed in breast-fed infants at 2 and 6 months.
  • Elevated mean albumin levels in breast-fed infants at 2 months.
  • No significant differences in alkaline phosphatase, IGF-I, IGFBP-3, or lactic dehydrogenase between groups; AST correlated positively with IGF-I at 2 months.

Conclusions:

  • Elevated AST in breast-fed infants is unlikely due to CMV, vitamin K deficiency, or macromolecular AST, as no other liver disease signs were present.
  • The study speculates that factors in human milk may induce hepatocytes, leading to higher AST levels.
  • Higher albumin and the AST-IGF-I association support the hypothesis of hepatocyte induction by human milk components.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Anatomy of the Intestines01:53

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.Small IntestinesThe small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small intestine...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...